![Sanna Hug](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Origen de la red de primer grado Sanna Hug.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
HBM Partners AG
![]() HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US.
7
| Private Company | Investment Managers | 7 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Sanna Hug a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Knight Capital Group, Inc.
![]() Knight Capital Group, Inc. Investment Banks/BrokersFinance Knight Capital Group, Inc. is a global financial services firm, which provides access to the capital markets across multiple asset classes to a broad network of clients, including buy and sell side firms, dealers, brokers, institutions, and corporations. It operates business through four segments: Market Making, Institutional Sales and Trading, Electronic Execution Services and Corporate and Other. The Market Making segment consists of market making in global equities and listed domestic options. It includes client, and to a lesser extent, non-client electronic market making activities in which they operate as a market maker in equity securities. The Institutional Sales and Trading segment includes global equity, exchange traded funds and fixed income sales and trading; reverse mortgage origination and securitization; capital markets; and asset management activities. Its business consists of execution and facilitation equities and fixed income transactions as agent on behalf of institutional clients, and they commit capital on behalf of its clients when needed. The Electronic Execution Services segment offers access via its electronic agency-based platforms to markets and self-directed trading in equities, equity options, fixed income, foreign exchange and futures contracts. The Corporate and Other segment invests in strategic financial services-oriented opportunities, allocates, deploys and monitors all capital, and maintains corporate overhead expenses and all other income and expenses that are not attributable to the other segments. The company was founded in 1995 and is headquartered in Jersey City, NJ. | Investment Banks/Brokers | Corporate Officer/Principal | |
CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Organ Recovery Systems, Inc.
![]() Organ Recovery Systems, Inc. Medical SpecialtiesHealth Technology Organ Recovery Systems, Inc. provides and transplantation technologies. Its products include LifePort sterile disposables, cargo carte, kidney perfusion solution, data station, battery cap, power cord, data cable, insulating cover and ice containers. The company was founded by David Kravitz in 1998 and is headquartered in Chicago, IL. | Medical Specialties | Director/Board Member | |
CoreCommodity Management LLC
![]() CoreCommodity Management LLC Investment ManagersFinance CoreCommodity Management LLC (CoreCommodity) is a registered investment advisor and hedge fund manager headquartered in Stamford, Connecticut. The firm was founded by Adam de Chiara and Bradford Klein in 2003 as Jefferies Asset Management LLC and changed their name to CoreCommodity Management LLC in 2012. They are a subsidiary of CoreCommodity Capital LLC, which is owned by CoreManagement LLC. CoreCommodity provides investment management services to sovereign wealth funds, public and corporate pensions, endowments and foundations, and other prominent institutional clients seeking commodities exposure. | Investment Managers | Corporate Officer/Principal | |
Foundation for Innovative New Diagnostics
![]() Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | Medical/Nursing Services | Chairman | |
LIFELINE SCIENTIFIC, INC | Medical Specialties | Director/Board Member | |
GlucoSentient, Inc.
![]() GlucoSentient, Inc. Medical/Nursing ServicesHealth Services GlucoSentient, Inc. develops personal glucose meters for diabetes patients. It has developed a technology that is transforming the personal glucose meter into a device that is detecting other non-glucose targets. The firm offers products such as Medical Diagnostics, Point-of-care tests, Immunoassay. The company was founded by Brian Wong, Tian Lan, Neil D. Kane and Yi Lu in 2011 and is headquartered in Champaign, IL. | Medical/Nursing Services | Director/Board Member | |
Credit Suisse AG
![]() Credit Suisse AG Investment ManagersFinance Credit Suisse AG is an investment management firm headquartered in Zurich, Switzerland. The firm was founded in 1856 and was acquired by UBS Group AG (SWX: UBSG) from Credit Suisse Group AG in 2023. Credit Suisse manages global and regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals worldwide. They also offer private banking and wealth management, investment banking, and corporate and business support services. | Investment Managers | Corporate Officer/Principal | |
MORPHOSYS AG | Biotechnology | Chairman | |
University of Cambridge | College/University | Undergraduate Degree | |
Roche Diagnostics GmbH
![]() Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Adnexus
![]() Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
Fairfield University | College/University | Undergraduate Degree | |
University of Wisconsin | College/University | Doctorate Degree | |
University of Kiel | College/University | Doctorate Degree | |
ESBATech, a Novartis Co. GmbH
![]() ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Ziemer Group AG
![]() Ziemer Group AG Medical SpecialtiesHealth Technology Ziemer Group AG develops, manufactures, and markets diagnostic and surgical ophthalmic products. Its products include FEMTO LDV, AMADEUS, GALILEI and PASCAL. The company was founded by Frank Ziemer in 1998 and is headquartered in Port, Switzerland. | Medical Specialties | Corporate Officer/Principal | |
ENANTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Emergent Technologies, Inc.
![]() Emergent Technologies, Inc. Investment ManagersFinance Emergent Technologies, Inc. (Emergent Technologies) is a venture capital firm founded in 1989 by Thomas A. Harlan. The firm is headquartered in Austin. Texas. | Investment Managers | Corporate Officer/Principal | |
Bellus Health (Innodia), Inc.
![]() Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Definiens AG
![]() Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Packaged Software | Chairman | |
Swiss Federal Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
Abbott Diagnostics, Inc.
![]() Abbott Diagnostics, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA. | Medical Specialties | Private Equity Investor | |
Pure Transplant Solutions, LLC
![]() Pure Transplant Solutions, LLC Medical SpecialtiesHealth Technology Pure Transplant Solutions LLC develops diagnostics, devices and therapeutics. The firm develops medical devices which will eliminate rejection in organ transplants. The company is headquartered in Austin, TX. | Medical Specialties | Corporate Officer/Principal | |
Cathay Industrial Biotech Ltd.
![]() Cathay Industrial Biotech Ltd. Chemicals: SpecialtyProcess Industries Cathay Industrial Biotech Ltd. develops, manufactures, and commercializes chemicals, fuels, and polymers. It offers dibasic acids, pentamethylene diamine, terryl for textiles, engineering polymers, toll production, and technology development. The company was founded by XiuCai Liu and QiXian Zhang in 1997 and is headquartered in Shanghai, China. | Chemicals: Specialty | Director of Finance/CFO | |
Psynova Neurotech Ltd.
![]() Psynova Neurotech Ltd. BiotechnologyHealth Technology Psynova Neurotech Ltd. provides commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. The company was founded by Sabine Bahn on August 1, 2005 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Consultant / Advisor | |
Gebrüder Meier AG
![]() Gebrüder Meier AG Other Consumer ServicesConsumer Services Gebrüder Meier AG is a company based in Regensdorf, Switzerland. The Swiss company provides repair services for electric motors and frequency converters. Part of ERNE AG Bauunternehmung, Gebrüder Meier AG was founded in 1998. Daniel G. Zeidler has been the CEO of the company since 2022. | Other Consumer Services | Director/Board Member | |
St. Gallen University of Applied Sciences | College/University | Doctorate Degree | |
Drexel University College of Medicine | College/University | Graduate Degree | |
Reha Technology AG
![]() Reha Technology AG Medical SpecialtiesHealth Technology Reha Technology AG designs, manufactures and distributes robotic-assisted systems for neuro-rehabilitation. Its products include G-EO system, nexstep, first mover and armotion. The company was founded in 2011 and is headquartered in Olten, Switzerland. | Medical Specialties | President | |
ConnectRN, Inc.
![]() ConnectRN, Inc. Internet Software/ServicesTechnology Services ConnectRN, Inc. operates as a mobile technology company connecting hospitals with available nurses. Its platform provides various tools to connect healthcare providers to qualified and available staff via an alert system that is sent to their mobile devices. The company is headquartered in Brookline, MA. | Internet Software/Services | Director/Board Member | |
Tripex Pharmaceuticals LLC
![]() Tripex Pharmaceuticals LLC Pharmaceuticals: OtherHealth Technology Tripex Pharmaceuticals LLC provides pharmaceutical services. The company is headquartered in Encinas, CA. | Pharmaceuticals: Other | Director/Board Member | |
INOZYME PHARMA, INC. | Pharmaceuticals: Major | Founder | |
NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Healthcare Advisors GmbH | Corporate Officer/Principal | ||
Nmt New Medical Technologies AG | Corporate Officer/Principal | ||
Tevard Biosciences, Inc.
![]() Tevard Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Tevard Biosciences, Inc. is a biotechnology company based in Cambridge, MA. Tevard Biosciences is focused on developing trna-based and other modulating therapies to cure a broad range of genetic diseases. The company is advancing the use of its novel suppressor trna, enhancer trna, and mrna amplifier platforms in neurological disorders, heart disease, and muscular dystrophies. The company was founded in 2017 by Warren Burt Lammert, Harvey F. Lodish, Daniel Fischer, and Jeffrey Coller. Daniel Fischer has been the CEO since 2017. | Miscellaneous Commercial Services | Director/Board Member | |
CATHAY BIOTECH INC. | Chemicals: Specialty | Director/Board Member | |
Regel Therapeutics Inc.
![]() Regel Therapeutics Inc. BiotechnologyHealth Technology Regel Therapeutics Inc. develops a proprietary technology platform related to gene therapy. The company is based in Cambridge, MA. The company was founded in 2020 by Navneet Matharu, Jordane Dimidschstein, Steven B. Ruchefsky, Michael Jasulavic, Orrin Devinsky. Steven B. Ruchefsky has been the CEO since 2020. | Biotechnology | Founder | |
Script Biosciences, Inc.
![]() Script Biosciences, Inc. Packaged SoftwareTechnology Services SCRIPT Biosciences, Inc. develops a genome editing platform. The American company was founded in 2020. Anil Namboodiripad has been the CEO of the company since 2021. | Packaged Software | Director/Board Member | |
Phifund Managers, LLC
![]() Phifund Managers, LLC Investment ManagersFinance Phifund Managers, LLC (Phifund Managers) is a venture capital firm founded in 2021.The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
AdrenoMed AG
![]() AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Founder | |
ALLENA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 27 |
Suiza | 11 |
Alemania | 6 |
Reino Unido | 4 |
Suecia | 2 |
Sectorial
Health Technology | 22 |
Consumer Services | 9 |
Finance | 8 |
Commercial Services | 4 |
Technology Services | 4 |
Operativa
Director/Board Member | 37 |
Corporate Officer/Principal | 19 |
Chairman | 12 |
Independent Dir/Board Member | 7 |
Private Equity Investor | 5 |
Las relaciones más conectadas
Insiders | |
---|---|
Gerald Heinz Möller | 29 |
Axel Bolte | 23 |
Michael Jasulavic | 12 |
Steven Mayer | 11 |
Ulrich Geilinger | 8 |
Joachim Rudolf | 5 |
Thomas Heimann | 2 |
- Bolsa de valores
- Insiders
- Sanna Hug
- Conexiones Empresas